Division of Pharmacy Professional Development

The University of Wisconsin-Madison School of Pharmacy continues to climb rankings! On, Wisconsin!

UW–Madison School of Pharmacy Ranked Among the Nation’s Best in Training Pharmacists - School of Pharmacy U.S. News & World Report ranks UW–Madison #6 Best Pharmacy School in 2026.

More than 2 million Americans could benefit from , but only about a quarter of them are getting the HIV prevention medication.

Billing mistakes. Stigma. Doctors who aren’t keeping up with the latest research. Those are just some of the hurdles that keep prevention medication out of reach for many Americans.

Effective but Underprescribed: HIV Prevention Meds Aren’t Reaching Enough People - KFF Health News PrEP has been available for more than a decade, but billing mistakes, lack of awareness, and lingering stigma keep many people from getting the lifesaving HIV prevention medication.

The retail and community pharmacy industries have been celebrating the landmark benefit manager reform (PBM) included in the Consolidated Appropriations Act of 2026.

Giving CMS the power to more closely oversee and their dealings with , this legislation has the chance to rid the pharmacy industry of underwater reimbursements, unfair contracting, and more.

What the Newest Landmark PBM Reform Means for the Pharmacy Industry | Drug Topics With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.

Ready to strengthen your impact on drug development teams?

Our CMC Project Team Leadership course equips pharmaceutical scientists with the critical skills to lead multidisciplinary teams, navigate CMC project challenges, and drive projects forward with confidence.

From team dynamics to regulatory insights, this course blends science and leadership in real-world contexts. Learn more and join us—invest in your leadership journey. 📈 👩‍🔬 👨‍🔬

Pharmacists are vital in managing supplement risks through medication reviews, patient education, and evidence-based guidance on supplement use.

Pharmacist Strategies for Navigating Supplement Use in Patients on TNF Inhibitors | Pharmacy Times Pharmacists are essential in guiding patients taking TNF inhibitors regarding supplement use, the risks of "immune boosters," and potential immunomodulatory therapy interactions.

Rejecting decades of science, the chair of the federal panel that recommends vaccines for Americans said that shots against and — and perhaps all diseases — should be optional, offered only in consultation with a clinician.

Vaccine Panel Chair Says Polio and Other Shots Should Be Optional, Rejecting Decades of Science Dr. Kirk Milhoan, a pediatric cardiologist who leads the Advisory Committee on Immunization Practices, said a person’s right to refuse a vaccine outweighed concerns about illness or death from infectious diseases.

Novo Nordisk has launched its oral version of the weight loss drug Wegovy in the US after its approval by the U.S. Food and Drug Administration.

The pharmaceutical company said the drug will be available from today at prices starting from $149 per month. The rate covers the 1.5 mg and 4 mg versions of the pill, with two higher doses – 9 mg and 25 mg – priced at $299 per month.

Novo Nordisk launches Wegovy pill at $149 a month Novo Nordisk has followed through on its pledge for a swift launch of the Wegovy pill for weight loss, and revealed its pricing for self-payers.

The administration is overhauling the list of routine shots recommended for all babies and children in the United States.

The Centers for Disease Control and Prevention (CDC) will no longer recommend every child receive for flu, hepatitis A and B, and RSV.

U.S. overhauls childhood vaccine schedule, recommends fewer shots The U.S. no longer broadly recommends vaccines for flu, hepatitis A and B, and RSV. Health officials say the guidance aligns with that of peer countries.

We at DPPD wish you a wonderful 2026!

See the link in comments to learn more about our continuing education opportunities for the new year.

The Wisconsin Opioid Overdose Response Center (WOORC) will continue for another year its life-saving work to reduce opioid deaths after receiving a no-cost extension of the federal grant from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA).

The WOORC is housed in the University of Wisconsin-Madison School of Pharmacy.

Doing the WOORC to Save Lives - School of Pharmacy Wisconsin Opioid Overdose Response Center Receives a grant extension to expand pharmacy-based solutions to the overdose crisis.

🩸 Advance Your Expertise in Antithrombotic Therapy!

Join us virtually for the 40th Annual Pharmacy Innovations Conference on Antithrombotic Therapy (PICAT) on November 7, 2024.

Hear from nationally recognized experts as they cover the latest updates on:
✅ Anticoagulation in transplant and low-body-weight patients
✅ Heparin resistance and DOAC drug interactions
✅ Factor XIa inhibitors and stroke management
✅ eGFR vs. CrCL in dosing decisions

Earn 6 CE hours and take part in interactive discussions with academic and industry leaders.

🔗 Register now: https://bit.ly/4n8jO1z to secure your virtual seat!